v3.24.2.u1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended
Jul. 31, 2024
Jul. 31, 2023
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss, including amounts attributable to noncontrolling interest $ (42,613) $ (104,107)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Stock-based compensation expense 91,221 78,698
Change in fair value of acquisition related contingent consideration 3,750 0
Charitable donation of common stock 5,914 5,350
Amortization of intangible assets 3,420 1,125
Depreciation expense 1,681 2,206
Amortization of deferred contract acquisition costs 22,946 20,619
Loss from equity method investment 0 2,108
Net amortization of premiums or discounts on short-term investments (9,141) (8,494)
Unrealized foreign exchange loss (gain), net (258) 825
Other non-cash expense (income), net 301 (103)
Changes in assets and liabilities:    
Accounts receivable 1,225 25,281
Prepaid expenses and other current assets 13,271 (4,248)
Deferred contract acquisition costs (20,955) (18,137)
Other non-current assets (497) (721)
Accounts payable 1,350 (1,023)
Accrued expenses and other current liabilities (21,633) 1,183
Accrued compensation and benefits (6,902) 2,611
Deferred revenue 14,838 11,175
Other non-current liabilities (8,083) 1,800
Net cash provided by operating activities 49,835 16,148
CASH FLOWS FROM INVESTING ACTIVITIES:    
Purchases of short-term investments (263,258) (334,996)
Proceeds from maturities of short-term investments 376,099 272,984
Purchases of property and equipment (1,551) (533)
Payments for business combination, net of cash acquired (20,210) 0
Payments for asset acquisition (7,314) 0
Escrow payment related to business combination, after acquisition date 0 (2,500)
Other investing activities 457 0
Net cash provided by (used in) investing activities 84,223 (65,045)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from the issuance of common stock upon exercise of stock options, including early exercises, net of repurchases 10,073 17,777
Issuance of common stock under employee stock purchase plan 7,932 7,751
Net cash provided by financing activities 18,005 25,528
Impact of foreign exchange on cash and cash equivalents (1,443) (1,308)
Net increase (decrease) in cash and cash equivalents 150,620 (24,677)
Cash and cash equivalents at beginning of period 287,996 297,902
Cash and cash equivalents at end of period 438,616 273,225
Supplemental disclosure of cash flow information:    
Cash paid for income taxes 1,803 4,187
Supplemental disclosure of non-cash investing and financing activities:    
Vesting of early exercised stock options 189 809
Unpaid property and equipment in accrued expenses 87 0
Unpaid direct transaction costs related to the asset acquisition in accrued expenses $ 346 $ 0